secwatch.observer — SEC 8-K summary
======================================

Issuer:     SANUWAVE Health, Inc. (SNWV)
CIK:        0001417663
Form:       8-K
Filed at:   2024-07-10T23:59:59+00:00
Accession:  0001140361-24-032784
Event type: earnings
Sentiment:  positive
Materiality: 0.75
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Sanuwave Health reports preliminary Q2 2024 revenue of $7.0-7.2M, highest quarterly revenue in history
--------------------------------------------------------------------------------

- Preliminary Q2 2024 revenue $7.0M-$7.2M; up 50%-54% vs Q2 2023 and highest quarterly revenue ever.
- UltraMist revenue grew >60% YoY and represents ~97% of total company revenue.
- UltraMist applicator sales set all-time quarterly record, accounting for ~65% of total revenue.
- Company expects to release full Q2 results in mid-August 2024; guidance at upper end of prior range.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1417663/000114036124032784/0001140361-24-032784-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1417663/000114036124032784/ef20032251_8k.htm
  HTML page:      https://secwatch.observer/filing/0001140361-24-032784

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer